5NG: [[(2~{S},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{R})-4-[[3-[2-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyldisulfanyl]ethylamino]-3-oxidanylidene-propyl]amino]-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-butyl] hydrogen phosphate
5NG is a Ligand Of Interest in 8VR6 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8VR6_5NG_A_201 | 71% | 56% | 0.104 | 0.925 | 0.72 | 0.96 | 3 | 7 | 0 | 0 | 100% | 1 |
| 6C37_5NG_A_301 | 81% | 17% | 0.078 | 0.972 | 2.47 | 1.19 | 18 | 7 | 0 | 0 | 77% | 0.7349 |
| 7OVV_5NG_B_301 | 72% | 4% | 0.128 | 0.953 | 3.68 | 2.19 | 31 | 22 | 3 | 0 | 100% | 1 |
| 5EGL_5NG_C_201 | 54% | 7% | 0.138 | 0.902 | 3.45 | 1.48 | 27 | 16 | 3 | 0 | 100% | 1 |
